References
[1] Brant L, Passaglia LG, Pinto-Filho MM, de Castilho FM, Ribeiro A, Nascimento BR. (2022). The Burden of Resistant Hyper-tension Across the World. Curr Hypertens Rep. 2022; 24:55-66 [PMID: 35118612 DOI: 10.1007/s11906-022-01173-w].
[2] Katsurada K, Shinohara K, Aoki J, Nanto S, Kario K. (2022). Renal denervation: basic and clinical evidence. Hypertens Res. 2022; 45:198-209 [PMID: 34921299 DOI: 10.1038/ s41440-021-00827-7].
[3] Azizi M, Mahfoud F, Weber M A, Sharp A, Schmieder R E, Lurz P, Lobo M D, Fisher N, Daemen J, Bloch M J, Basile J, Sanghvi K, Saxena M, Gosse P, Jenkins J S, Levy T, Persu A, Kably B, Claude L, Reeve-Stoffer H, Mcclure C, Kirtane A J. (2022). Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial. JAMA Cardiol. 2022; 7:1244-1252 [PMID: 36350593 DOI: 10.1001/jamacardio.2022.3904].
[4] Kario K, Yokoi Y, Okamura K, Fujihara M, Ogoyama Y, Yamamoto E, Urata H, Cho J M, Kim C J, Choi S H, Shinohara K, Mukai Y, Ikemoto T, Nakamura M, Seki S, Matoba S, Shibata Y, Sugawara S, Yumoto K, Tamura K, Yoshihara F, Nakamura S, Kang W C, Shibasaki T, Dote K, Yokoi H, Matsuo A, Fujita H, Takahashi T, Kang H J, Sakata Y, Horie K, Inoue N, Sasaki K I, Ueno T, Tomita H, Morino Y, Nojima Y, Kim C J, Matsumoto T, Kai H, Nanto S. (2022). Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. Hypertens Res. 2022; 45:221-231 [PMID: 34654905 DOI: 10.1038/s41440-021-00754-7].
[5] Fengler K, Rommel K P, Blazek S, Besler C, Hartung P, von Roeder M, Petzold M, Winkler S, Hollriegel R, Desch S, Thiele H, Lurz P. (2019). A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients with Resistant Hypertension (RADIOSOUND-HTN). Circulation. 2019; 139:590-600 [PMID: 30586691
DOI: 10.1161/CIRCULATIONAHA.118.037654].
[6] Kirtane A J, Sharp A, Mahfoud F, Fisher N, Schmieder R E, Daemen J, Lobo M D, Lurz P, Basile J, Bloch M J, Weber M A, Saxena M, Wang Y, Sanghvi K, Jenkins J S, Devireddy C, Rader F, Gosse P, Sapoval M, Barman N C, Claude L, Augustin D, Thackeray L, Mullin C M, Azizi M. (2023). Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials. JAMA Cardiol. 2023; 8:464-473 [PMID: 36853627 DOI: 10.1001/jamacardio.2023.0338].
[7] Silverwatch J, Marti KE, Phan MT, Amin H, Roman YM, Pasupuleti V, Banach M, Barboza JJ, Hernandez AV. (2021). Renal Denervation for Uncontrolled and Resistant Hypertension: Systematic Reviewand Network Meta-Analysis of Randomized Trials. J Clin Med. 2021; 10:782 [PMID: 33669195 DOI: 10.3390/jcm10040782].
[8] Barbato E, Azizi M, Schmieder RE, Lauder L, Böhm M, Brouwers S, Bruno RM, Dudek D, Kahan T, Kandzari DE, Lüscher TF, Parati G, Pathak A, Ribichini FL, Schlaich MP, Sharp ASP, Sudano I, Volpe M, Tsioufis C, Wijns W, Mahfoud F. (2023). Renal denervation in the management of hypertension in adults. Aclinicalconsensus statement of the ESC Council on Hypertension and the EuropeanAssociation of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2023; 44:1313-1330 [PMID: 36790101 DOI: 10.1093/eurheartj/ehad054].
[9] Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D. (2021). Renal denervation for resistant hypertension. Cochrane Database Syst Rev. 2021;11:D11499 [PMID: 34806762 DOI: 10.1002/14651858.CD011499.pub3].
[10] Schmieder RE, Ott C, Toennes SW, Bramlage P, Gertner M, Dawood O, Baumgart P, O'Brien B, Dasgupta I, Nickenig G, Or-miston J, Saxena M, Sharp ASP, Sievert H, Spinar J, Starek Z, Weil J, Wenzel U, Witkowski A, Lobo MD. (2018). Phase II randomized sham-controlled study of renal denervation for individualswith uncontrolled hypertension - WAVE IV. J Hypertens. 2018; 36:680-689 [PMID: 29035942 DOI: 10.1097/HJH.0000000000001584].
[11] Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, Saxena M, Feyz L, Rader F, Lurz P, Sayer J, Sapoval M, Levy T, Sanghvi K, Abraham J, Sharp ASP, Fisher NDL, Bloch MJ, Reeve-Stoffer H, Coleman L, Mullin C, Mauri L; RADIANCE-HTN Investigators. (2018). Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTNSOLO): a multicentre, international, single-blind, randomised, sham-controlledtrial. Lancet. 2018; 391: 2335-2345 [PMID: 29803590 DOI: 10.1016/S0140-6736(18)31082-1].